Medical Weight Loss for Hawthorne, California Residents

Hawthorne, California residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Hawthorne through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Honest pricing for Hawthorne patients: compounded semaglutide starts at $166 per month ($499 for the 90-day program) and tirzepatide from $233 per month, billed separately. No distance surcharge for California residents. Doctor review just $119 (medication separate).

Why Hawthorne Residents Choose New Hope Weight Loss

We made New Hope easy to start without making it less serious. A Hawthorne patient can go from first visit to a physician-approved plan without insurance paperwork, prior authorizations, or a single drive to an office. The $119 review with Dr. Anjmun Sharma is flat, the medication price is published, and the whole thing happens by telehealth. Low friction to begin, real medicine once you do, the same standard everyone in California gets.

Medical weight loss for Hawthorne is handled end-to-end online: intake, the $119 physician review with Dr. Sharma, dose titration, and follow-ups, all by secure video, with no drive and no pharmacy line.

If you are searching for a weight-loss physician in Hawthorne, the honest answer is that ours is in Costa Mesa, and thanks to telehealth that puts California patients exactly where local ones are. We care for patients throughout downtown Hawthorne and the South Bay of Los Angeles County. Follow-up check-ins are handled remotely, so adjusting your dose is simple whether you live near downtown Hawthorne or out toward downtown Hawthorne and the South Bay of Los Angeles County.

Whether you live in central Hawthorne or out toward the edges of California, you see the same physician, Dr. Anjmun Sharma, and pay the same flat pricing with no distance surcharge. For patients across Hawthorne, compounded semaglutide starts at $166 per month, with a 90-day program available for $499, and the medication cost is kept separate from the $119 physician review. California is our home state and our physical clinic sits in Costa Mesa, but we care for patients across the rest of the state by secure telehealth.

GLP-1 Weight Loss Programs Available

Two GLP-1 paths, one plan built around you

The 90-Day Metabolic Reset uses semaglutide, the same active ingredient in Wegovy and Ozempic. From $166 a month, or $499 for the full 90 days, it pairs medication with monthly check-ins. Branded-drug trials showed average loss of about 15 to 17 percent. Compounded semaglutide is not FDA-approved and not brand-identical, and results vary from person to person.

Want a stronger option? Ask about tirzepatide

From $233 a month, tirzepatide combines GLP-1 and GIP action. Trial participants on qualifying doses saw up to 22.5 percent body-weight loss, a top-dose number rather than the average. It carries the same active ingredient as Mounjaro and Zepbound.

Your $119 physician review comes first. Medication is billed separately. HSA, FSA, Klarna, and Affirm are all welcome for Hawthorne patients.

How Telehealth Works for Hawthorne

Here is how the whole thing works, start to finish, for anyone in Hawthorne.

First, you fill out an intake and quiz about your weight history and current health. Next, Dr. Sharma looks it over and meets you by secure video, almost always within 48 hours, to see whether compounded semaglutide or tirzepatide fits your situation. Then, if she prescribes, a state-licensed 503(a) pharmacy ships the medication to your Hawthorne address in cold-pack packaging built to protect it on the road. After that, every follow-up is a video visit, so the care continues no matter where you are in .

Frequently Asked Questions, Hawthorne

I am searching for weight loss care near Hawthorne. Where are you?

We are based in Costa Mesa, California, where our only physical clinic operates. Patients in Hawthorne, California connect with us by telehealth instead of visiting. Dr. Anjmun Sharma conducts a video consult to review your goals and confirm whether you qualify for a compounded GLP-1 medication program.

Do I need to be seen in person if I live in Hawthorne?

Not at all. The telehealth format covers Hawthorne patients from start to finish, so no clinic visit is ever required. You speak with Dr. Sharma by video, and once you are approved, compounded medication ships to Hawthorne in cold-pack packaging built to keep it cool and stable.

What are the program costs for Hawthorne patients?

The physician review is priced at $119. Compounded semaglutide is available from $166 a month or $499 for the 90-day plan, and tirzepatide from $233 a month. Medication is invoiced separately. Payment options include HSA, FSA, Klarna, and Affirm, and Hawthorne patients face no distance surcharge.

What areas of Hawthorne do you serve?

We serve patients from across Hawthorne by telehealth, including downtown Hawthorne and the South Bay of Los Angeles County.

What does treatment cost for Hawthorne patients?

The same flat pricing nationwide: a $119 physician visit, compounded semaglutide from $166/month, and compounded tirzepatide from $233/month, with medication billed separately. HSA, FSA, Klarna, and Affirm are accepted, and there is no distance surcharge for Hawthorne.

Hawthorne Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Hawthorne, California by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.